elysium healthcare holdings 2 limited
elysium healthcare holdings 2 limited Company Information
Company Number
10419351
Next Accounts
Mar 2025
Shareholders
elysium healthcare holdings 1 limited
Group Structure
View All
Industry
Non-trading company
Registered Address
2 imperial place, maxwell road, borehamwood, WD6 1JN
Website
www.elysiumhealthcare.co.ukelysium healthcare holdings 2 limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE HOLDINGS 2 LIMITED at £0 based on a Turnover of £0 and 0.52x industry multiple (adjusted for size and gross margin).
elysium healthcare holdings 2 limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE HOLDINGS 2 LIMITED at £0 based on an EBITDA of £0 and a 9.9x industry multiple (adjusted for size and gross margin).
elysium healthcare holdings 2 limited Estimated Valuation
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE HOLDINGS 2 LIMITED at £136.8m based on Net Assets of £120.7m and 1.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elysium Healthcare Holdings 2 Limited Overview
Elysium Healthcare Holdings 2 Limited is a live company located in borehamwood, WD6 1JN with a Companies House number of 10419351. It operates in the non-trading company sector, SIC Code 74990. Founded in October 2016, it's largest shareholder is elysium healthcare holdings 1 limited with a 100% stake. Elysium Healthcare Holdings 2 Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Elysium Healthcare Holdings 2 Limited Health Check
Pomanda's financial health check has awarded Elysium Healthcare Holdings 2 Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 2 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (4.4%)
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (40)
- Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 48.9%, this is a similar level of debt than the average (47.6%)
- - Elysium Healthcare Holdings 2 Limited
- - Industry AVG
ELYSIUM HEALTHCARE HOLDINGS 2 LIMITED financials
Elysium Healthcare Holdings 2 Limited's latest turnover from June 2023 is 0 and the company has net assets of £120.7 million. According to their latest financial statements, we estimate that Elysium Healthcare Holdings 2 Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Turnover | 0 | 371,788,000 | 336,204,000 | 284,751,000 | 232,397,000 | 176,806,000 | 11,607,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 0 | 274,598,000 | 247,573,000 | 208,549,000 | 166,167,000 | 121,303,000 | 8,459,000 |
| Gross Profit | 0 | 97,190,000 | 88,631,000 | 76,202,000 | 66,230,000 | 55,503,000 | 3,148,000 |
| Admin Expenses | 0 | 95,118,000 | 80,890,000 | 89,821,000 | 65,644,000 | 56,145,000 | 3,945,000 |
| Operating Profit | 0 | 2,072,000 | 7,741,000 | -13,619,000 | 586,000 | -642,000 | -797,000 |
| Interest Payable | 0 | 30,692,000 | 31,133,000 | 30,477,000 | 35,533,000 | 18,612,000 | 1,734,000 |
| Interest Receivable | 13,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 13,000 | -28,620,000 | -23,392,000 | -44,096,000 | -34,947,000 | -19,254,000 | 11,000 |
| Tax | 0 | -27,467,000 | -7,093,000 | 3,732,000 | -3,442,000 | 4,509,000 | 29,000 |
| Profit After Tax | 13,000 | -56,087,000 | -30,485,000 | -40,364,000 | -38,389,000 | -14,745,000 | 40,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 13,000 | -56,087,000 | -30,485,000 | -40,364,000 | -38,389,000 | -14,745,000 | 40,000 |
| Employee Costs | 0 | 227,462,000 | 201,081,000 | 158,254,000 | 130,282,000 | 99,539,000 | 6,494,000 |
| Number Of Employees | 8,107 | 7,698 | 6,127 | 4,713 | 3,290 | 2,501 | |
| EBITDA* | 0 | 41,419,000 | 45,604,000 | 37,213,000 | 33,106,000 | 24,520,000 | 1,049,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 296,816,000 | 270,572,000 | 256,669,000 | 234,363,000 | 192,583,000 | 116,573,000 |
| Intangible Assets | 0 | 321,969,000 | 347,933,000 | 368,907,000 | 400,764,000 | 341,834,000 | 240,682,000 |
| Investments & Other | 235,918,000 | 9,953,000 | 9,107,000 | 5,543,000 | 1,413,000 | 1,128,000 | 0 |
| Debtors (Due After 1 year) | 0 | 1,390,000 | 1,175,000 | 1,100,000 | 1,100,000 | 1,100,000 | 0 |
| Total Fixed Assets | 235,918,000 | 630,128,000 | 628,787,000 | 632,219,000 | 637,640,000 | 536,645,000 | 357,255,000 |
| Stock & work in progress | 0 | 346,000 | 357,000 | 443,000 | 331,000 | 252,000 | 89,000 |
| Trade Debtors | 0 | 29,680,000 | 28,164,000 | 14,036,000 | 19,752,000 | 27,173,000 | 13,425,000 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 21,726,000 | 14,518,000 | 15,936,000 | 4,351,000 | 3,048,000 | 3,264,000 |
| Cash | 0 | 6,107,000 | 12,254,000 | 2,127,000 | 8,128,000 | 9,801,000 | 83,606,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 695,000 | 0 |
| total current assets | 0 | 57,859,000 | 55,293,000 | 32,542,000 | 32,562,000 | 40,969,000 | 100,384,000 |
| total assets | 235,918,000 | 687,987,000 | 684,080,000 | 664,761,000 | 670,202,000 | 577,614,000 | 457,639,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 9,114,000 | 5,502,000 | 5,261,000 | 6,826,000 | 4,079,000 | 439,000 |
| Group/Directors Accounts | 69,000 | 0 | 0 | 0 | 0 | 0 | 45,000,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 5,892,000 | 4,697,000 | 4,634,000 | 4,422,000 | 3,484,000 | 3,352,000 |
| other current liabilities | 0 | 28,958,000 | 25,346,000 | 22,073,000 | 15,852,000 | 16,738,000 | 29,680,000 |
| total current liabilities | 69,000 | 43,964,000 | 35,545,000 | 31,968,000 | 27,100,000 | 24,301,000 | 78,471,000 |
| loans | 115,198,000 | 444,370,000 | 417,092,000 | 401,683,000 | 362,727,000 | 317,318,000 | 159,202,000 |
| hp & lease commitments | 0 | 131,727,000 | 131,008,000 | 126,304,000 | 126,592,000 | 97,607,000 | 97,388,000 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 16,090,000 | 16,100,000 | 0 | 0 | 0 | 0 |
| provisions | 0 | 106,814,000 | 83,226,000 | 73,212,000 | 86,157,000 | 74,458,000 | 63,903,000 |
| total long term liabilities | 115,198,000 | 699,001,000 | 647,426,000 | 601,199,000 | 575,476,000 | 489,383,000 | 320,493,000 |
| total liabilities | 115,267,000 | 742,965,000 | 682,971,000 | 633,167,000 | 602,576,000 | 513,684,000 | 398,964,000 |
| net assets | 120,651,000 | -54,978,000 | 1,109,000 | 31,594,000 | 67,626,000 | 63,930,000 | 58,675,000 |
| total shareholders funds | 120,651,000 | -54,978,000 | 1,109,000 | 31,594,000 | 67,626,000 | 63,930,000 | 58,675,000 |
| Jun 2023 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | 0 | 2,072,000 | 7,741,000 | -13,619,000 | 586,000 | -642,000 | -797,000 |
| Depreciation | 0 | 17,989,000 | 16,518,000 | 14,736,000 | 12,813,000 | 10,146,000 | 840,000 |
| Amortisation | 0 | 21,358,000 | 21,345,000 | 36,096,000 | 19,707,000 | 15,016,000 | 1,006,000 |
| Tax | 0 | -27,467,000 | -7,093,000 | 3,732,000 | -3,442,000 | 4,509,000 | 29,000 |
| Stock | 0 | -11,000 | -86,000 | 112,000 | 79,000 | 163,000 | 89,000 |
| Debtors | 0 | 8,939,000 | 12,785,000 | 5,869,000 | -6,118,000 | 14,632,000 | 16,689,000 |
| Creditors | 0 | 3,612,000 | 241,000 | -1,565,000 | 2,747,000 | 3,640,000 | 439,000 |
| Accruals and Deferred Income | 0 | 3,612,000 | 3,273,000 | 6,221,000 | -886,000 | -12,942,000 | 29,680,000 |
| Deferred Taxes & Provisions | 0 | 23,588,000 | 10,014,000 | -12,945,000 | 11,699,000 | 10,555,000 | 63,903,000 |
| Cash flow from operations | 0 | 35,836,000 | 39,340,000 | 26,675,000 | 49,263,000 | 15,487,000 | 78,322,000 |
| Investing Activities | |||||||
| capital expenditure | 0 | 0 | 0 | -18,533,000 | -20,533,000 | -295,228,000 | |
| Change in Investments | 235,918,000 | 846,000 | 3,564,000 | 4,130,000 | 285,000 | 1,128,000 | 0 |
| cash flow from investments | -846,000 | -3,564,000 | -4,130,000 | -18,818,000 | -21,661,000 | -295,228,000 | |
| Financing Activities | |||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 69,000 | 0 | 0 | 0 | 0 | -45,000,000 | 45,000,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 115,198,000 | 27,278,000 | 15,409,000 | 38,956,000 | 45,409,000 | 158,116,000 | 159,202,000 |
| Hire Purchase and Lease Commitments | 0 | 1,914,000 | 4,767,000 | -76,000 | 29,923,000 | 351,000 | 100,740,000 |
| other long term liabilities | 0 | -10,000 | 16,100,000 | 0 | 0 | 0 | 0 |
| share issue | |||||||
| interest | 13,000 | -30,692,000 | -31,133,000 | -30,477,000 | -35,533,000 | -18,612,000 | -1,734,000 |
| cash flow from financing | 235,918,000 | -1,510,000 | 5,143,000 | 12,735,000 | 81,884,000 | 114,855,000 | 361,843,000 |
| cash and cash equivalents | |||||||
| cash | 0 | -6,147,000 | 10,127,000 | -6,001,000 | -1,673,000 | -73,805,000 | 83,606,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | -6,147,000 | 10,127,000 | -6,001,000 | -1,673,000 | -73,805,000 | 83,606,000 |
elysium healthcare holdings 2 limited Credit Report and Business Information
Elysium Healthcare Holdings 2 Limited Competitor Analysis
Perform a competitor analysis for elysium healthcare holdings 2 limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other young companies, companies in WD6 area or any other competitors across 12 key performance metrics.
elysium healthcare holdings 2 limited Ownership
ELYSIUM HEALTHCARE HOLDINGS 2 LIMITED group structure
Elysium Healthcare Holdings 2 Limited has 1 subsidiary company.
Ultimate parent company
P HEALTH SARL
#0102578
2 parents
ELYSIUM HEALTHCARE HOLDINGS 2 LIMITED
10419351
1 subsidiary
elysium healthcare holdings 2 limited directors
Elysium Healthcare Holdings 2 Limited currently has 2 directors. The longest serving directors include Dr Quazi Haque (Nov 2018) and Mr Colin McCready (Jul 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Quazi Haque | United Kingdom | 56 years | Nov 2018 | - | Director |
| Mr Colin McCready | United Kingdom | 49 years | Jul 2023 | - | Director |
P&L
June 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
120.7m
0%
total assets
235.9m
0%
cash
0
0%
net assets
Total assets minus all liabilities
elysium healthcare holdings 2 limited company details
company number
10419351
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
October 2016
age
9
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
June 2023
previous names
dmwsl 840 limited (December 2016)
accountant
-
auditor
-
address
2 imperial place, maxwell road, borehamwood, WD6 1JN
Bank
-
Legal Advisor
-
elysium healthcare holdings 2 limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to elysium healthcare holdings 2 limited. Currently there are 0 open charges and 2 have been satisfied in the past.
elysium healthcare holdings 2 limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELYSIUM HEALTHCARE HOLDINGS 2 LIMITED. This can take several minutes, an email will notify you when this has completed.
elysium healthcare holdings 2 limited Companies House Filings - See Documents
| date | description | view/download |
|---|
